Mark Jason Heath Ellison - Chief Development Officer at Opiant Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Development Officer
Stock Symbol
OPNT
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Jason Heath Ellison since 12/25/2023

Holdings reported by Mark Jason Heath Ellison for Opiant Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $20.00 Mar 2, 2023 Direct
Common Stock 0 $20.00 Mar 2, 2023 Indirect
Stock Option (right to buy) 0 $10.00 Mar 2, 2023 Direct Common Stock

Transactions reported by Mark Jason Heath Ellison for Opiant Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.